Vor Biopharma (VOR) P/E Ratio
P/E Ratio as of Jul 2, 2025: -0.96
Average-0.3305
Median-0.1500
Minimum-1.07
Maximum-0.1200
-0.96
Past Month-0.80 (500.00%)
The P/E ratio for Vor Biopharma (VOR) is -0.96 as of Jul 2, 2025. This represents a increase of 81.13% compared to its 12-month average P/E ratio of -0.53. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Vor Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vor Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vor Biopharma to industry peers.
Vor Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vor Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vor Biopharma to industry peers.
Vor Biopharma (VOR) P/E Ratio Insights
See Vor Biopharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Vor Biopharma (VOR)
Order type
Buy in
Order amount
Est. shares
0 shares
Vor Biopharma (VOR) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $1.43 | -0.95 |
| Jun 2, 2025 | $0.2343 | -0.16 |
| May 1, 2025 | $0.661 | -0.39 |
| Apr 1, 2025 | $0.62 | -0.36 |
| Mar 3, 2025 | $0.952 | -0.58 |
| Feb 3, 2025 | $1.34 | -0.81 |
| Jan 2, 2025 | $1.12 | -0.68 |
Vor Biopharma (VOR) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.96 | +43.28% |
| 2024 | -0.67 | -44.17% |
| 2023 | -1.20 | -58.48% |
| 2022 | -2.89 | -52.78% |
| 2021 | -6.12 | — |
FAQs About Vor Biopharma (VOR) P/E ratio
The latest P/E ratio of Vor Biopharma (VOR) is -0.96, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Vor Biopharma’s last 12-month average P/E ratio is -0.53, compared to its current P/E ratio of -0.96. This reflects a increase of 81.13%.
Vor Biopharma’s current P/E ratio of -0.96 is higher than its last 12-month average P/E of -0.53. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Vor Biopharma’s average P/E ratio over the last 3 years is -1.27. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Vor Biopharma’s average P/E ratio over the last 5 years is -4.07. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.